只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-16 2026-06-17 | NRSN NeuroSense Therapeutics Ltd. | Ben-Noon Alon Officer · Chief Executive Officer | 买入(P) | 250,000 | US$0.80 | US$200,000.00 | 4,534,233 | SEC |
| 2026-06-15 2026-06-16 | BUSE FIRST BUSEY CORP /NV/ | Cassens Michael David Director | 卖出(S) | 750 | US$28.92 | US$21,690.00 | 139,642 | SEC |
| 2026-06-15 2026-06-16 | BUSE FIRST BUSEY CORP /NV/ | Cassens Michael David Director | 卖出(S) | 5,528 | US$29.00 | US$160,312.00 | 134,114 | SEC |
| 2026-06-12 2026-06-16 | ST Sensata Technologies Holding plc | Caljouw Lynne J Officer · EVP, Chief HR Officer | 卖出(S) | 2,723 | US$50.35 | US$137,103.05 | 66,405 | SEC |
| 2026-06-12 2026-06-15 | CHGG CHEGG, INC | ROSENSWEIG DANIEL Director,Officer · PRESIDENT, CEO, EXEC CHAIRMAN | 卖出(S) | 6,337 | US$1.11 | US$7,034.07 | 7,633,778 | SEC |
| 2026-06-12 2026-06-15 | CHGG CHEGG, INC | ROSENSWEIG DANIEL Director,Officer · PRESIDENT, CEO, EXEC CHAIRMAN | 卖出(S) | 1,956 | US$1.11 | US$2,171.16 | 7,640,115 | SEC |
| 2026-06-02 2026-06-04 | CCSI Consensus Cloud Solutions, Inc. | HEALY ELAINE Director | 卖出(S) | 4,000 | US$34.27 | US$137,080.00 | 27,658 | SEC |
| 2026-06-01 2026-06-01 | SNSE Sensei Biotherapeutics, Inc. | Peyer James TenPercentOwner,Other | 卖出(S) | 24,524 | US$20.00 | US$490,480.00 | 130,618 | SEC |
| 2026-06-01 2026-06-01 | SNSE Sensei Biotherapeutics, Inc. | Peyer James TenPercentOwner,Other | 卖出(S) | 476 | US$21.14 | US$10,062.64 | 130,142 | SEC |
| 2026-06-01 2026-06-01 | SNSE Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc TenPercentOwner | 卖出(S) | 24,524 | US$20.00 | US$490,480.00 | 130,618 | SEC |
| 2026-06-01 2026-06-01 | SNSE Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc TenPercentOwner | 卖出(S) | 476 | US$21.14 | US$10,062.64 | 130,142 | SEC |
| 2026-05-20 2026-05-22 | ST Sensata Technologies Holding plc | Stott David K Officer · EVP, General Counsel | 卖出(S) | 6,335 | US$47.40 | US$300,279.00 | 39,687 | SEC |
| 2026-05-18 2026-05-20 | SXT SENSIENT TECHNOLOGIES CORP | Hoang Thierry Officer · VP, Asia Pacific Group | 卖出(S) | 400 | US$115.19 | US$46,076.00 | 13,909 | SEC |
| 2026-05-15 2026-05-18 | BUSE FIRST BUSEY CORP /NV/ | Cassens Michael David Director | 卖出(S) | 750 | US$26.11 | US$19,582.50 | 140,392 | SEC |
| 2026-05-12 2026-05-13 | SENS Senseonics Holdings, Inc. | ROEDER DOUGLAS A Director | 买入(P) | 22,686 | US$5.56 | US$126,134.16 | 144,635 | SEC |
| 2026-05-12 2026-05-12 | SRTS Sensus Healthcare, Inc. | Sachetta Eric Director | 买入(P) | 1,500 | US$3.34 | US$5,010.00 | 143,613 | SEC |
| 2026-05-04 2026-05-06 | SXT SENSIENT TECHNOLOGIES CORP | Hoang Thierry Officer · VP, Asia Pacific Group | 卖出(S) | 439 | US$114.15 | US$50,111.85 | 14,309 | SEC |
| 2026-04-30 2026-05-01 | SXT SENSIENT TECHNOLOGIES CORP | Morris Steven B Officer · President, Color Group | 卖出(S) | 200 | US$114.58 | US$22,916.00 | 6,759.37 | SEC |
| 2026-04-30 2026-05-01 | SXT SENSIENT TECHNOLOGIES CORP | Winder Anstalt TenPercentOwner | 卖出(S) | 2,127,566 | US$109.69 | US$2.33亿 | 4,177,348 | SEC |
| 2026-04-30 2026-05-01 | SXT SENSIENT TECHNOLOGIES CORP | Winder Investment Anstalt TenPercentOwner | 卖出(S) | 2,127,566 | US$109.69 | US$2.33亿 | 4,177,348 | SEC |
| 2026-04-30 2026-05-01 | SXT SENSIENT TECHNOLOGIES CORP | Winder Pte. Ltd. TenPercentOwner | 卖出(S) | 2,127,566 | US$109.69 | US$2.33亿 | 4,177,348 | SEC |
| 2026-04-30 2026-05-01 | SXT SENSIENT TECHNOLOGIES CORP | Haldor Foundation TenPercentOwner | 卖出(S) | 2,127,566 | US$109.69 | US$2.33亿 | 4,177,348 | SEC |
| 2026-04-15 2026-04-16 | BUSE FIRST BUSEY CORP /NV/ | Cassens Michael David Director | 卖出(S) | 750 | US$26.75 | US$20,062.50 | 140,888 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 2,115 | US$28.94 | US$61,208.10 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 2,115 | US$28.94 | US$61,208.10 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 2,115 | US$28.94 | US$61,208.10 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 2,115 | US$28.94 | US$61,208.10 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 205 | US$29.71 | US$6,090.55 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 205 | US$29.71 | US$6,090.55 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 205 | US$29.71 | US$6,090.55 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 205 | US$29.71 | US$6,090.55 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 4,423 | US$31.38 | US$138,793.74 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 4,423 | US$31.38 | US$138,793.74 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 4,423 | US$31.38 | US$138,793.74 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 4,423 | US$31.38 | US$138,793.74 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 300 | US$32.25 | US$9,675.00 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 300 | US$32.25 | US$9,675.00 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 300 | US$32.25 | US$9,675.00 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 300 | US$32.25 | US$9,675.00 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,108 | US$33.38 | US$36,985.04 | 133,986 | SEC |
| 2026-04-07 2026-04-09 | ST Sensata Technologies Holding plc | Caljouw Lynne J Officer · EVP, Chief HR Officer | 卖出(S) | 2,913 | US$34.71 | US$101,110.23 | 72,842 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 45 | US$31.96 | US$1,438.20 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 45 | US$31.96 | US$1,438.20 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 45 | US$31.96 | US$1,438.20 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 45 | US$31.96 | US$1,438.20 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,214 | US$31.02 | US$37,658.28 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,214 | US$31.02 | US$37,658.28 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,214 | US$31.02 | US$37,658.28 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,214 | US$31.02 | US$37,658.28 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,104 | US$31.02 | US$34,246.08 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,104 | US$31.02 | US$34,246.08 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,104 | US$31.02 | US$34,246.08 | 141,029 | SEC |
| 2026-04-06 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,104 | US$31.02 | US$34,246.08 | 141,029 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,134 | US$34.80 | US$39,463.20 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,134 | US$34.80 | US$39,463.20 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,134 | US$34.80 | US$39,463.20 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,134 | US$34.80 | US$39,463.20 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 374 | US$33.35 | US$12,472.90 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 374 | US$33.35 | US$12,472.90 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 374 | US$33.35 | US$12,472.90 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 374 | US$33.35 | US$12,472.90 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,794 | US$32.60 | US$58,484.40 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,794 | US$32.60 | US$58,484.40 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,794 | US$32.60 | US$58,484.40 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,794 | US$32.60 | US$58,484.40 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,265 | US$31.75 | US$40,163.75 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,265 | US$31.75 | US$40,163.75 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,265 | US$31.75 | US$40,163.75 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,265 | US$31.75 | US$40,163.75 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 3,099 | US$30.86 | US$95,635.14 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 3,099 | US$30.86 | US$95,635.14 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 3,099 | US$30.86 | US$95,635.14 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 3,099 | US$30.86 | US$95,635.14 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,276 | US$34.75 | US$44,341.00 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,276 | US$34.75 | US$44,341.00 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,276 | US$34.75 | US$44,341.00 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,276 | US$34.75 | US$44,341.00 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 26 | US$33.47 | US$870.22 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 26 | US$33.47 | US$870.22 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 26 | US$33.47 | US$870.22 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 26 | US$33.47 | US$870.22 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 701 | US$35.55 | US$24,920.55 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 701 | US$35.55 | US$24,920.55 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 701 | US$35.55 | US$24,920.55 | 144,974 | SEC |
| 2026-04-02 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 701 | US$35.55 | US$24,920.55 | 144,974 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,613 | US$34.59 | US$55,793.67 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,613 | US$34.59 | US$55,793.67 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,613 | US$34.59 | US$55,793.67 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,613 | US$34.59 | US$55,793.67 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,161 | US$31.53 | US$36,606.33 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,161 | US$31.53 | US$36,606.33 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,161 | US$31.53 | US$36,606.33 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,161 | US$31.53 | US$36,606.33 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 46 | US$34.75 | US$1,598.50 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 46 | US$34.75 | US$1,598.50 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 46 | US$34.75 | US$1,598.50 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 46 | US$34.75 | US$1,598.50 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,104 | US$31.52 | US$34,798.08 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,104 | US$31.52 | US$34,798.08 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,104 | US$31.52 | US$34,798.08 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,104 | US$31.52 | US$34,798.08 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 3,401 | US$35.46 | US$120,599.46 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 3,401 | US$35.46 | US$120,599.46 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 3,401 | US$35.46 | US$120,599.46 | 147,731 | SEC |
| 2026-04-01 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 3,401 | US$35.46 | US$120,599.46 | 147,731 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 186 | US$30.48 | US$5,669.28 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 186 | US$30.48 | US$5,669.28 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 186 | US$30.48 | US$5,669.28 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 186 | US$30.48 | US$5,669.28 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 616 | US$24.69 | US$15,209.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 616 | US$24.69 | US$15,209.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 616 | US$24.69 | US$15,209.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 616 | US$24.69 | US$15,209.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,770 | US$25.32 | US$44,816.40 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,770 | US$25.32 | US$44,816.40 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,770 | US$25.32 | US$44,816.40 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,770 | US$25.32 | US$44,816.40 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,048 | US$26.73 | US$28,013.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,048 | US$26.73 | US$28,013.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,048 | US$26.73 | US$28,013.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,048 | US$26.73 | US$28,013.04 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 17 | US$27.78 | US$472.26 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 17 | US$27.78 | US$472.26 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 17 | US$27.78 | US$472.26 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 17 | US$27.78 | US$472.26 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,957 | US$31.45 | US$61,547.65 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,957 | US$31.45 | US$61,547.65 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,957 | US$31.45 | US$61,547.65 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,957 | US$31.45 | US$61,547.65 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 411 | US$32.60 | US$13,398.60 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 411 | US$32.60 | US$13,398.60 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 411 | US$32.60 | US$13,398.60 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 411 | US$32.60 | US$13,398.60 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 191 | US$24.28 | US$4,637.48 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 191 | US$24.28 | US$4,637.48 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 191 | US$24.28 | US$4,637.48 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 191 | US$24.28 | US$4,637.48 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,251 | US$25.17 | US$31,487.67 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 1,251 | US$25.17 | US$31,487.67 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 1,251 | US$25.17 | US$31,487.67 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 1,251 | US$25.17 | US$31,487.67 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 57 | US$27.11 | US$1,545.27 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 57 | US$27.11 | US$1,545.27 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 57 | US$27.11 | US$1,545.27 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 57 | US$27.11 | US$1,545.27 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 5 | US$28.41 | US$142.05 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 5 | US$28.41 | US$142.05 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 5 | US$28.41 | US$142.05 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 5 | US$28.41 | US$142.05 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 87 | US$31.52 | US$2,742.24 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 87 | US$31.52 | US$2,742.24 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 87 | US$31.52 | US$2,742.24 | 146,657 | SEC |
| 2026-03-31 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 87 | US$31.52 | US$2,742.24 | 146,657 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 518 | US$25.85 | US$13,390.30 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 518 | US$25.85 | US$13,390.30 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 518 | US$25.85 | US$13,390.30 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 518 | US$25.85 | US$13,390.30 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 卖出(S) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 卖出(S) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 2,992 | US$25.08 | US$75,039.36 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 2,992 | US$25.08 | US$75,039.36 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 2,992 | US$25.08 | US$75,039.36 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 2,992 | US$25.08 | US$75,039.36 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 4,995 | US$25.99 | US$129,820.05 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 4,995 | US$25.99 | US$129,820.05 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 4,995 | US$25.99 | US$129,820.05 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 4,995 | US$25.99 | US$129,820.05 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 1,176 | US$26.70 | US$31,399.20 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,176 | US$26.70 | US$31,399.20 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 1,176 | US$26.70 | US$31,399.20 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 1,176 | US$26.70 | US$31,399.20 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-30 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 370 | US$27.68 | US$10,241.60 | 145,678 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 10,643 | US$26.29 | US$279,804.47 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 10,643 | US$26.29 | US$279,804.47 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 10,643 | US$26.29 | US$279,804.47 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 10,643 | US$26.29 | US$279,804.47 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 4,384 | US$27.28 | US$119,595.52 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 4,384 | US$27.28 | US$119,595.52 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 4,384 | US$27.28 | US$119,595.52 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 4,384 | US$27.28 | US$119,595.52 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 买入(P) | 294 | US$28.13 | US$8,270.22 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 买入(P) | 294 | US$28.13 | US$8,270.22 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM GROUP MANAGEMENT LLC TenPercentOwner | 买入(P) | 294 | US$28.13 | US$8,270.22 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ENGLANDER ISRAEL A TenPercentOwner | 买入(P) | 294 | US$28.13 | US$8,270.22 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | ICS OPPORTUNITIES II LLC TenPercentOwner | 卖出(S) | 469 | US$26.77 | US$12,555.13 | 142,360 | SEC |
| 2026-03-27 2026-05-15 | SNSE Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC TenPercentOwner | 卖出(S) | 469 | US$26.77 | US$12,555.13 | 142,360 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| SENS | 129,878.7587 | 0 | 235,527.6682 | 55.14% | B, Q, N |